Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1997 Apr;120(8):1453–1460. doi: 10.1038/sj.bjp.0701074

Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney

Markus van der Giet 1, Mohammed Khattab 1, Jan Börgel 1, Hartmut Schlüter 1, Walter Zidek 1,*
PMCID: PMC1564629  PMID: 9113365

Abstract

  1. The activation of various purinoceptors in rat renal vasculature by P1,P2-diadenosine pyrophosphate (Ap2A), P1,P3-diadenosine triphosphate (Ap3A), P1,P4-diadenosine tetraphosphate (Ap4A), P1,P5-diadenosine pentaphosphate (Ap5A), P1,P6-diadenosine hexaphosphate (Ap6A) was studied by measuring their effects of perfusion pressure of a rat isolated perfused kidney.

  2. The vasoconstrictive response to Ap5A was completely due to P2X purinoceptor activation, that to Ap4A and Ap6 was P2X purinoceptor mediated to a large extent, as evidenced by the inhibitory effects of suramin and pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid tetrasodium (PPADS).

  3. The vasoconstrictive effects of Ap2A and Ap3A were mostly due to stimulation of A1-receptors, as shown by the inhibitory effect of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX).

  4. The vasoconstrictive response to Ap6A was partially insensitive to A1 and P2X purinoceptor blockers.

  5. In raised tone preparations Ap2A and Ap3A evoked vasodilatation, which was blocked by the A2 receptor blocker, 3,7-dimethyl-1-propargylxanthine (DMPX).

  6. In raised tone preparations Ap4A evoked vasodilatation when the P2-purinoceptors were blocked by suramin.

  7. The activation of different purinoceptor subtypes by diadenosine phosphates critically depends on the number of phosphate groups.

Keywords: Purinoceptors, diadenosine phosphates, P2-receptors, P1-receptors, rat isolated perfused kidney, vasoconstriction, vasodilatation

Full Text

The Full Text of this article is available as a PDF (408.8 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES